Antitumor activity of 5-formamido-1- D-ribofuranosylthioimidazole-4-carboxamide 2',3',5'-triformate in a variety of animal tumors.
D000230:Adenocarcinoma / Q000188:drug therapy / Q000378:metabolism; D000577:Amides / Q000494:pharmacology; D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D001201:Ascites / Q000188:drug therapy / Q000378:metabolism; D005260:Female; D005561:Formates / Q000494:pharmacology; D006168:Guinea Pigs; D007274:Injections, Intraperitoneal; D007939:Leukemia L1210 / Q000188:drug therapy / Q000378:metabolism; D007942:Leukemia, Experimental / Q000188:drug therapy / Q000378:metabolism; D008297:Male; D015122:Mercaptopurine / Q000494:pharmacology; D051379:Mice; D008815:Mice, Inbred Strains; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy* / Q000378:metabolism; D009705:Nucleosides / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D012513:Sarcoma, Experimental / Q000188:drug therapy / Q000378:metabolism; D014184:Transplantation, Homologous
D000577:Amides; D000970:Antineoplastic Agents; D005561:Formates; D009705:Nucleosides; D015122:Mercaptopurine